2 weeks ago
TPG, Temasek Sell 12.64% Stake in Dr Agarwals Health Care
Two big investment companies, TPG and Temasek, owned a large part of an eye care hospital company called Dr Agarwals Health Care.
On one day, they sold some of their shares to other investors through the stock market.
They sold about 12.64% of the whole company.
In return, they got around ₹2,008 crore, which is a very large amount of money.
Even after selling, they still own a big part of the company and remain its largest public shareholders.
Other investment firms, such as ICICI Prudential Mutual Fund and Allianz, bought many of those shares.
When a lot of shares are sold at once, the price often goes down, and that is what happened here.
The share price fell close to 6% that day.
Just before the sale, the company had announced that its profit grew by 44.6% compared with last year.
The company is expanding, now running 304 eye care facilities across 10 countries.
TPG and Temasek sold a 12.64% stake in Dr Agarwals Health Care for ₹2,008 crore through open market bulk deals on the NSE.
Over 4 crore equity shares were offloaded at Rs 501.03–501.54 apiece, with a combined deal value of ₹2,007.94 crore.
After the sale, TPG's affiliate Hyperion Investments' holding fell to 15.47% and Temasek's Claymore Investments' stake fell to 5.17%.
ICICI Prudential Mutual Fund, Invesco MF, Polar Capital and Allianz Global Investors bought nearly a 5% stake worth ₹761.60 crore.
Shares of Dr Agarwals Health Care fell nearly 6% to close at Rs 511, following the stake sale and strong Q1FY27 results.
- Who
- Investment firms TPG and Temasek (through affiliates Hyperion Investments Pte Ltd and Claymore Investments (Mauritius) Pte Ltd), with buyers including ICICI Prudential Mutual Fund, Invesco MF, Polar Capital and Allianz Global Investors.
- What
- A collective sale of a 12.64% stake in the eye care chain Dr Agarwals Health Care for ₹2,008 crore via open market bulk deals.
- Where
- On the National Stock Exchange (NSE); the company is based in Chennai.
- When
- On Wednesday, as reported in an article published on August 13, 2026.
- Why
- The sellers' rationale was not explicitly stated in the article; the sale followed Dr Agarwals' 44.6% year-on-year rise in consolidated profit after tax for Q1FY27.
Key facts
- Stake sold
- 12.64% by TPG and Temasek
- Deal value
- ₹2,007.94 crore (≈₹2,008 crore)
- Shares offloaded
- Over 4 crore equity shares
- Selling price range
- Rs 501.03–501.54 per share
- Key buyers
- ICICI Prudential MF, Invesco MF, Polar Capital, Allianz Global Investors (~5% stake worth ₹761.60 crore)
- Remaining stakes
- Hyperion Investments (TPG) 15.47%; Claymore Investments (Temasek) 5.17%
- Q1FY27 performance
- Consolidated PAT ₹55.02 crore (+44.6% YoY); revenue ₹614.02 crore (+26%)
- Network size
- 304 facilities across 10 countries
Sources
Related news
TPG Sells 6.66% Aster DM Quality Care Stake
SoftBank Sells Second Lenskart Stake Worth ₹2,888 Crore
Alpha Wave Global Exits Aye Finance With ₹322 Crore Sale
Qualcomm Sells ₹184 Crore Stake in Shadowfax Deal
Blackstone exits EPL through Rs 2,032 crore stake sale
